Probiotic dietary supplementation in patients with stage 3 and 4 chronic kidney disease: a 6-month pilot scale trial in Canada

References

• Alvarez-Olmos MI, Oberhelman RA. Probiotic agents and infectious diseases: a modern perspective on a traditional therapy. Clin Infect Dis 2001;32:1567-76
   PubMed Web of Science ®Google Scholar
• Doron S, Gorbach SL. Probiotics: their role in the treatment and prevention of disease. Expert Rev Anti Infect Ther 2006;4:261-75
   PubMedGoogle Scholar
• Gill HS, Guarner F. Probiotics and human health: a clinical perspective. Postgrad Med J 2004;80:516-26
   PubMed Web of Science ®Google Scholar
• Huebner ES, Surawicz CM. Probiotics in the prevention and treatment of gastrointestinal infections. Gastroenterol Clin North Am 2006;35:355-65
   PubMed Web of Science ®Google Scholar
• Ezendam J, van Loveren H. Probiotics: immunomodulation and evaluation of safety and efficacy. Nutr Rev 2006;64:1-14
   PubMed Web of Science ®Google Scholar
• Ranganathan N, Patel B, Ranganathan P, et al. Probiotic amelioration of azotemia in 5/6th nephrectomized Sprague-Dawley rats. The Scientific World Journal 2005;5:652-60
   Web of Science ®Google Scholar
• Ranganathan N, Patel BG, Ranganathan P, et al. In vitro and in vivo assessment of intraintestinal bacteriotherapy in chronic kidney disease. ASAIO J 2006;52:70-9
   PubMed Web of Science ®Google Scholar
• Ranganathan N, Friedman EA. Progress in devising a bowel based probiotic therapy for uremia. Poster Presentation, BIO International Convention, 2007, Boston, MA
   Google Scholar
• Dunn SR, Marczely J, Ranganathan P, et al. Probiotics extend survival in untreated 5/6 nephrectomized rats: possible use for probiotics as an adjunct in chronic renal failure (CRF). Poster Presentation, J Am Soc Nephrol 2003;14
   PubMed Web of Science ®Google Scholar
• Patel B, Zelenaia O, Dheer R, et al. Oral bacteriotherapy effectively reduces severity of azotemia in 5/6th nephrectomized rats. Poster Presentation, J Am Soc Nephrol, 2003;14
   PubMed Web of Science ®Google Scholar
• Willis L, Handa R, Paterson R, et al. Oral probiotic treatment for uremia in a porcine model of chronic renal failure. Poster Presentation, J Am Soc Nephrol, 2004;15
   Google Scholar
• Patel B, Marczely J, Ranganathan N, et al. Gut based uremia therapy: oral bacteriotherapy effectively reduces severity of azotemia in 5/6th nephrectomized mini pigs. Poster Presentation, International Society of Nephrology Conference on Prevention of Progression of Renal Disease, 2004
   Google Scholar
• Ranganathan N, Patel B, Ranganathan P, et al. Probiotics reduce azotemia in Gottingen minipigs. Poster Presentation, 3rd World Congress of Nephrology, 2005
   Google Scholar
• Friedman EA, Macherone A, Ranganathan N, et al. Gut based uremia therapy: simultaneously eliminate urea, creatinine and uric acid. J Am Soc Nephrol, 2001;12:71-2A
   PubMedGoogle Scholar
• Patel B, Macherone A, Marczely J, et al. Viability of probiotics in gastric juice and artificial intestinal fluid. J Am Soc Nephrol, 2002;13:767A
   Web of Science ®Google Scholar
• Ranganathan N, Macherone A, Patel B, et al. Urea hydrolysis and ammonia uptake by Bacillus pasteurii. Poster Presentation, 10th International Congress on Nutrition and Metabolism in Renal Disease, 2002
   Google Scholar
• Ranganathan N, Macherone A, Patel B, et al. Probiotics to eliminate nitrogenous metabolites. Poster Presentation, 10th International Congress on Nutrition and Metabolism in Renal Disease, 2002
   Google Scholar
• Ranganathan N, Macherone A, Patel B, et al. Probiotics to eliminate nitrogenous metabolites. Poster Presentation, 10th International Congress on Nutrition and Metabolism in Renal Disease, 2002
   Google Scholar
• Marczely J, Dheer R, Zelenaia O, et al. Rate of urea hydrolysis by Streptococcus thermophilus KB19 is comparable to soil bacterium Bacillus pasteurii and genetically engineered urealytic E. coli. Poster Presentation, J Am Soc Nephrol, 2003;14
   Web of Science ®Google Scholar
• Zelenaia O, Patel G, Dheer R, et al. Streptococcus thermophilus KB19 is a potential component of a probiotic regimen applicable in enteric dialysis for uremia. Poster Presentation, J Am Soc Nephrol, 2003;14
   Web of Science ®Google Scholar
• Patel B, Ranganathan N, Friedman EA. Artificial swallowable kidney formulation. Poster Presentation, American Society of Artificial and Internal Organs – International Society of Artificial and Internal Organs Joint Conference, 2003
   Google Scholar
• Patel B, Ranganathan N, Zelenaia O, et al. Substitution of the kidney function by the bowel in azotemia. Poster Presentation, J Am Soc Nephrol, 2004; 15
   Google Scholar
• Dheer R, Chordia T, Pechenyak B, et al. Kibow Biotics is preferred and superior to yogurt for uremia applications. Poster Presentation, J Am Soc Nephrol, 2004; 15
   Google Scholar
• Marczely J, Dheer R, Ranganathan P, et al. Probiotic formulation in vitro effect on phenol and p-cresol levels. Poster Presentation, J Am Soc Nephrol, 2004
   Google Scholar
• Patel B, Dheer R, Pechenyak B, Marczely J, et al. Mode of delivery and dosage are important factors for uremia therapy with probiotics. Poster Presentation J Am Soc Nephrol, 2004
   Google Scholar
• Chordia T, Dheer R, Pechenyak, et al. Significance of dosage for effective clinical application of probiotics. Poster Presentation, J Am Soc Nephrol, 2004
   Google Scholar
• Patel B, Marczely J, Ranganathan P, et al. Gut based uremia therapy: continued in vitro and in vivo R&D investigations on the application of oral probiotic bacteriotherapy towards chronic kidney disease (CKD) patients. 12th International Congress on Nutrition and Metabolism in Renal Disease - Free Communication FC-A8
   Google Scholar
• Patel B, Zelenaia O, Dheer R, et al. Gut-based uremia therapy: in vitro R&D investigations of an oral probiotic microbial formulation with the aid of a simulated human intestinal microbial ecosystem (SHIME) biochemical reactor. Poster Presentation, International Society of Nephrology Conference on Prevention of Progression of Renal Disease, 2004
   Google Scholar
• Patel B, Dheer R, Marczely J, et al. Comparative microbial viability analysis in two delivery formats -- gelcaps or admixed with food/diet. Poster Presentation, 12th International Congress on Nutrition and Metabolism in Renal Disease, 2004
   Google Scholar
• Patel B, Dheer R, Marczely J, et al. Short term effect of temperature on Kibow Biotics Poster Presentation, 3rd World Congress of Nephrology, Singapore, 2005
   Google Scholar
• Ranganathan P, Marczely J, Dheer J, et al. Initial trial of probiotic bacteria as therapy for uremia in dogs. Poster Presentation, J Am Soc Nephrol, 2004
   Google Scholar
• Ranganathan N, Patel G, Ranganathan P, et al. Effect of feeding Kibow Biotics to cats and dogs in kidney failure. Poster Presentation, 39th Annual Meeting of American Society of Nephrology, 2006
   Google Scholar
• Ranganathan N, Patel G, Ranganathan P, et al. Progress in devising a bowel based probiotic therapy for uremia. 5th Annual Meeting on Prevention in Renal Disease, 2006, Toronto, Canada
   Google Scholar
• Palmquist R. A preliminary clinical evaluation of Kibow Biotics®, a probiotic agent, on feline azotemia. J Am Holistic Vet Med Assoc, 2006;24:23-7
   Google Scholar